We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Unveiling MannKind (MNKD) Q4 Outlook: Wall Street Estimates for Key Metrics
Read MoreHide Full Article
Wall Street analysts expect MannKind (MNKD - Free Report) to post quarterly earnings of $0.03 per share in its upcoming report, which indicates a year-over-year increase of 50%. Revenues are expected to be $75.66 million, up 29.4% from the year-ago quarter.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
Bearing this in mind, let's now explore the average estimates of specific MannKind metrics that are commonly monitored and projected by Wall Street analysts.
The combined assessment of analysts suggests that 'Revenues- Royalties- collaborations' will likely reach $26.10 million. The estimate indicates a change of +24.1% from the prior-year quarter.
The average prediction of analysts places 'Revenues- Revenue- collaborations and services' at $27.07 million. The estimate suggests a change of +56.9% year over year.
Analysts expect 'Revenues- Net revenue- commercial product sales' to come in at $21.63 million. The estimate suggests a change of +7.1% year over year.
Over the past month, MannKind shares have recorded returns of -4.5% versus the Zacks S&P 500 composite's -0.5% change. Based on its Zacks Rank #3 (Hold), MNKD will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Unveiling MannKind (MNKD) Q4 Outlook: Wall Street Estimates for Key Metrics
Wall Street analysts expect MannKind (MNKD - Free Report) to post quarterly earnings of $0.03 per share in its upcoming report, which indicates a year-over-year increase of 50%. Revenues are expected to be $75.66 million, up 29.4% from the year-ago quarter.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
Bearing this in mind, let's now explore the average estimates of specific MannKind metrics that are commonly monitored and projected by Wall Street analysts.
The combined assessment of analysts suggests that 'Revenues- Royalties- collaborations' will likely reach $26.10 million. The estimate indicates a change of +24.1% from the prior-year quarter.
The average prediction of analysts places 'Revenues- Revenue- collaborations and services' at $27.07 million. The estimate suggests a change of +56.9% year over year.
Analysts expect 'Revenues- Net revenue- commercial product sales' to come in at $21.63 million. The estimate suggests a change of +7.1% year over year.
View all Key Company Metrics for MannKind here>>>
Over the past month, MannKind shares have recorded returns of -4.5% versus the Zacks S&P 500 composite's -0.5% change. Based on its Zacks Rank #3 (Hold), MNKD will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>